Overexpressed GCS has been found in drug-resistant cancer cells and in tumors [3], [14]–[17], [46], [47]; however, whether ceramide glycosylation by GCS constitutes a significant mechanism by which tumors develop the resistance has been less studied. The gene discussed is UGCG; the disease is cancer.